In the last trading session, 1.04 million shares of the Basel Medical Group Ltd (NASDAQ:BMGL) were traded. Most recently the company’s share price was $3.10, and it changed around -$0.36 or -10.40% from the last close, which brings the market valuation of the company to $58.25M. BMGL currently trades at a discount to its 52-week high of $9.40, offering almost -203.23% off that amount. The share price’s 52-week low was $0.91, which indicates that the current value has risen by an impressive 70.65% since then. We note from Basel Medical Group Ltd’s average daily trading volume that its 10-day average is 4.12 million shares, with the 3-month average coming to 5.35 million.

Basel Medical Group Ltd (NASDAQ:BMGL) trade information

Instantly BMGL has showed a red trend with a performance of -10.40% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 4.92 on recent trading dayincreased the stock’s daily price by 36.99%. The company’s shares are currently down -30.18% year-to-date, but still down -29.71% over the last five days. On the other hand, Basel Medical Group Ltd (NASDAQ:BMGL) is 17.87% up in the 30-day period. We can see from the shorts that 0.45 million shares have been sold at a short interest cover period of 0.04 day(s).

BMGL Dividends

Basel Medical Group Ltd’s next quarterly earnings report is expected to be released in July.

Basel Medical Group Ltd (NASDAQ:BMGL)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 67.81% of Basel Medical Group Ltd shares.